Montco biopharm firm sold for $930M, shares soar
October 16, 2019 at 15:05 PM EDT
The Blue Bell company's shareholders could get another $140 million is its lead drug candidate is approved.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|